Recently, it was shown that mutations in the NER helicase gene ERCC2 detected in urothelial carcinoma of the bladder cause NER deficiency in cell line models and that ERCC2 mutations are associated with platinum sensitivity in some bladder cancer clinical cohorts4,5. This evidence concerns the gene ERCC2 and bladder transitional cell carcinoma.